Z-0921-2025 Class II Ongoing
FDA device recall Z-0921-2025 was initiated by DRG International, Inc. on Oct 7, 2024 and is designated Class II. Reason for recall: The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed… The recall status is ongoing. Affected quantity: 10 units.
Recall details
- Product Type
- Devices
- Report Date
- Jan 22, 2025
- Initiation Date
- Oct 7, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10 units
Product description
DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361
Reason for recall
The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.
Distribution pattern
Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.
Code information
UDI: (01)04048474053616(17)20251130(10)429K084-1. Lot Number: 429K084-1
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0921-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026